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In the last decade, various groups have found evidence of
nitric oxide production by mitochondrial nitric oxide
synthase (mNOS) in a range of experimental models.
However, little is known about the role of mNOS in renal
ischemia–reperfusion (I/R) injury and its possible involvement
in the apoptotic pathway. We analyzed the role of mNOS in
apoptosis promotion in rat kidney I/R and its direct
implication through experiments in which isolated kidney
mitochondria were subjected to hypoxia/reoxygenation.
Results showed that neuronal NOS located in the inner
mitochondrial membrane is upregulated during renal I/R and
that this upregulation, together with the increase in nitric
oxide production, is involved in the generation of
intramitochondrial peroxynitrite, which in turn leads to
cytochrome c release and apoptosis induction in renal I/R.
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Ischemia–reperfusion (I/R)-induced acute renal failure is a
common and costly clinical problem associated with high
morbidity and mortality in hospitalized patients. Nitric oxide
(NO), an endogenous signaling molecule, and NO synthase
(NOS) are involved in various ischemic or hypoxic renal
situations and are both important contributors to the patho-
physiology of acute renal failure associated with the I/R
syndrome.1,2 Among contributors to the damage associated
to I/R, it is well known that the combination of reactive
oxygen/nitrogen species and NO results in the formation of
cytotoxic metabolites such as peroxynitrite, protein tyrosine
nitration, or hydroxyl radical production. In these cases, NO
production acts as a promoter of different species that may
lead to deleterious responses such as necrosis or apoptosis.3,4
Moreover, the importance of NO- and peroxynitrite-
mediated apoptosis has been recognized clinically in a variety
of dysfunctions and transplant diseases.5,6
Many apoptotic factors activate programmed cell death
via cytochrome c release, among them sustained mitochon-
drial NO generation and peroxynitrite formation.7,8 Peroxy-
nitrite is a highly reactive molecule that exerts its cytotoxic
effects by inducing mitochondrial membrane depolarization
and by cytochrome c release.9–11 Its formation inside the
mitochondria during an I/R event becomes significant when
the superoxide formed during the oxidative stress reacts with
the high concentrations of mitochondrial NO. A role in acute
renal failure (ARF) has also been reported for this NO
metabolite.12
As regards the biological systems that produce NO, it is
commonly accepted that the main sources are the three
different NOS isoforms: neuronal (nNOS), endothelial
(eNOS), or inducible (iNOS). These isoforms are expressed
in mammals and differ in their functions, amino-acid
sequence, post-translational modification, and cellular loca-
tion. In the last decade, several groups have provided
experimental evidence for the production of mitochondrial
NO using a range of techniques and experimental mod-
els.13–17 One study reported the presence of a constitutively
expressed and continuously active Ca2þ -dependent NOS in
mitochondria (mNOS), located in the inner mitochondrial
membrane, able to regulate mitochondrial respiration, and
mitochondrial transmembrane potential.18 Since its discovery,
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many studies have tried to depict the enzyme in different
tissues and organs such as the brain, heart, or liver.14–16 Some
authors reported that mNOS strongly bound calmodulin,
had an iNOS-like immunoreactivity and a molecular weight
between 125–130 kDa, findings suggesting that it is similar to
iNOS.15 However, other authors provide evidence that
mNOS may be nNOS or eNOS,14,19–21 and indeed recent
studies indicate that mNOS is neither eNOS, nNOS, nor
iNOS.22 However, it seems to be widely agreed that mNOS is
the a-isoform of neuronal NOS, with a different pattern of
acylation from endothelial NOS and phosphorylated at the
COOH-terminal end.23 This theory is supported by the fact
that nNOS-KO mice did not have mNOS.16
In spite of these results with experimental models, little is
known about the role of mNOS in the renal I/R injury.
Here, we show that nNOS located in the inner
mitochondria is upregulated during renal I/R. We hypothe-
sized that nNOS intramitochondrial upregulation, together
with the increased NO production, is involved in the
generation of intramitochondrial peroxynitrite, which in
turn leads to the cytochrome c release and apoptosis
induction in I/R-induced ARF.
RESULTS
Nitration of proteins in the intramitochondrial and cytosolic
fraction
Nitrotyrosine Western blot has been used as marker of
peroxynitrite formation. Peroxynitrite reacts with a variety of
cellular targets, among them, L-tyrosine, which is converted
to 3-nitro-L-tyrosine.
As shown in Figure 1a, protein nitration in the
intramitochondrial fraction was increased in the I/R group
with respect to controls. This increase was observed in
proteins with molecular weights of 60, 55, 47, 43, 41, 40, and
38 kDa. This increase in nitration was reduced in the groups
in which NO (I/RþNG-nitro-L-arginine methyl ester
(L-NAME)) or peroxynitrite activity (I/Rþ 5,10,15,20-tetra-
kis-(N-methyl-4-pyridyl) porphinato-iron III (FeTMPyP))
were pharmacologically inhibited.
Interestingly, there was no clear difference in the patterns
of nitrated proteins in the cytosolic fraction between the
groups (Figure 2a).
Apoptotic markers
Cytochrome c released to the cytosol, caspase-3 activity and
terminal deoxynucleotidyl transferase-mediated dUTP nick-
end labeling (TUNEL) assay were used as markers of
apoptosis.
Figure 3 shows the Western blot of cytochrome c released
to the cytosol in the different groups. Cytochrome c release
was greater in the I/R group than in the control group, and
clearly lower in the groups with L-NAME and FeTMPyP
administration.
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60 kDa 605.37 ± 36.40 1642.39 ± 48.3* 450.33 ± 45.8+ 140.54 ± 31.2+
55 kDa 742.17 ± 30.29 1075.71 ± 40.5* 477.36 ± 49.5+ 360.43 ± 51.2+
47 kDa 930.38 ± 47.6 1078.01 ± 36.5* 801.73 ± 31.3+ 751.60 ± 46.2+
43 kDa 975.81 ± 54.3 1627.75 ± 42.6* 776.81 ± 30.29+ 702.39 ± 48.23+
41 kDa 1596.24 ± 47.21 1679.92 ± 52.3 882.93 ± 44.4+ 1066.03 ± 32.6+
40 kDa 1043.28 ± 57.7 1516.86 ± 36.6* 848.99 ± 39.7+ 963.37 ± 45.4+
38 kDa 1034.01 ± 39.9 1163.02 ± 56.5* 510.72 ± 38.6+ 438.61 ± 51.8+
a
b
Figure 1 | Western blot for nitrotyrosine of mitochondrial
fraction. (a) Representative Western blot for nitrotyrosine of
mitochondrial fraction of tissue homogenate. 1, Control; 2, I/R; 3,
I/Rþ L-NAME; and 4, I/Rþ FeTMPyP (n¼ 6). (b) Densitometric analysis
of nitrotyrosine bands corresponding to 60, 55, 47, 43, 41, 40,
and 38 kDa (n¼ 6). 1, Control; 2, I/R; 3, I/Rþ L-NAME; and 4,
I/Rþ FeTMPyP. Data are expressed as mean7s.d.
*Po0.05 vs C; þPo0.05 vs I/R.
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Figure 3 | Western blot for released cytochrome c. Western blot
analysis showing (upper part) the expression of cytochrome c
released to the cytosolic fraction of kidney under different
experimental conditions, and (lower part) the result of actin
Western blot (n¼ 6). 1, Control; 2, I/R; 3, I/Rþ L-NAME; 4,
I/Rþ FeTMPyP; and 5, positive control.
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60 kDa 498.60 ± 43.4 551.65 ± 39.6 645.05 ± 56.7 655.94 ± 55.8
42 kDa 584.33 ± 59.6 530.28 ± 60.5 780.59 ± 39.6 697.70 ± 46.2
35 kDa 494.30 ± 36.6 492.4 ± 42.4 562.3 ±  62.3 525.10 ± 30.5
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b
Figure 2 | Western blot for nitrotyrosine of cytosolic fraction.
(a) Representative Western blot for nitrotyrosine of cytosolic fraction
of tissue homogenate. 1, Control; 2, I/R; 3, I/Rþ L-NAME; and 4,
I/Rþ FeTMPyP (n¼ 6). (b) Densitometric analysis of nitrotyrosine
bands corresponding to 60, 42, and 35 kDa (n¼ 6). 1, Control; 2, I/R;
3, I/Rþ L-NAME; and 4, I/Rþ FeTMPyP. Data are expressed as
mean7s.d. *Po0.05 vs C; þPo0.05 vs I/R.
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Caspase-3 activity increased in the animals subjected to
45 min of ischemia followed by 24 h of reperfusion. Both
L-NAME and FeTMPyP administration dramatically reduced
the activity of this key apoptotic enzyme (Figure 4).
The determination of apoptosis in situ with immunohis-
tochemical staining (TUNEL assay) is shown in Figure 5,
where positive apoptotic cells showed a dark brown stain. To
prevent possible differences owing to the renal area selected,
all the sections correspond to the deep cortex–outer medulla
region of the kidney. In agreement with changes in caspase-3
activity, the I/R group showed more apoptotic cells (Figure
5b) than controls (Figure 5a). The increase was reduced in
L-NAME (Figure 5c) and peroxynitrite scavenger (Figure 5d)
administration (Figure 6).
Although the decrease in the apoptotic parameters in the
pharmacologically treated groups was clear, L-NAME admin-
istration increased the intratubular edema damage induced
by the I/R, whereas FeTMPyP was clearly able to reduce the
area affected. The edema is visible in Figure 5 (asterisk).
NO production
I/R increased the generation of NO, reflected in this study by
increased nitrite production (Figure 7). This production was
significantly decreased when the animals were treated
previously with the L-NAME or the peroxynitrite scavenger
FeTMPyP.
Mitochondrial nNOS upregulation
Figure 8 depicts the reverse transcription-polymerase chain
reaction (RT-PCR) method used to quantify nNOS expres-
sion levels in the kidney mitochondrial fraction. Results
confirmed the overexpression of nNOS in the I/R group
compared to control animals. No bands were found in the
mitochondrial fraction for iNOS or eNOS in controls or in
I/R groups (data not shown).
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Figure 4 | Caspase-3-like activity. Caspase-3-like activity in the
kidney homogenates of the following groups (n¼ 6). C, control; I/R,
ischemia–reperfusion; I/RþNAME, I/Rþ L-NAME administration;
and I/Rþ FeTMPyP, I/Rþperoxynitrite scavenger. *Po0.05 vs C;
þPo0.05 vs I/R.
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Figure 5 | Representative TUNEL staining of kidney samples after
45 min of ischemia and 24 h of reperfusion (n¼ 6). Positive cells
are shown as a dark brown stain. (a) Control; (b), I/R; (c), I/Rþ L-NAME
administration; and (d), I/Rþ FeTMPyP. Asterisks reflect intratubular
edema damage.
nNOS
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Figure 8 | Representative picture of nNOS PCR blots in the
upper part illustrate the mitochondrial fractions of the kidney
homogenate (n¼ 6). The actin result is shown in the lower part.
C, control; and I/R, ischemia–reperfusion.
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Figure 7 | Nitrite production (nmol/mg prot) in ischemic
kidney under different experimental conditions. C, Control;
I/R, ischemia–reperfusion; I/RþNAME, I/Rþ L-NAME administration;
and I/Rþ FeTMPyP, I/Rþ peroxynitrite scavenger (n¼ 6).
*Po0.05 vs C; þPo0.05 vs I/R.
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Figure 6 | Total positive cells per field in TUNEL staining. C,
Control; I/R, ischemia–reperfusion; I/RþNAME, I/Rþ l-NAME
administration; and I/Rþ FeTMPyP, I/Rþperoxynitrite scavenger
(n¼ 6). *Po0.05 vs C; þPo0.05 vs I/R.
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Isolated mitochondria subjected to hypoxia/reoxygenation
To assess directly the mitochondrial nNOS involvement in
cytochrome c release, we performed an additional experiment
in which isolated kidney mitochondria were subjected to
hypoxia in the presence or absence of an nNOS inhibitor.
Figure 9 shows the cytochrome c content retained in the
isolated kidney mitochondria and cytochrome c release to the
medium in three different groups.
Isolated mitochondrial extracts subjected to hypoxia/
reoxygenation provoked a massive release of the total mito-
chondrial cytochrome c into the supernatant (Figure 9b)
compared to controls (Figure 9a). By contrast, inhibition of
mNOS in the hypoxic group, by the use of the specific nNOS
inhibitor N-omega-propyl-L-arginine, retained a large
amount of cytochrome c inside the mitochondria (Figure
9c), thus indicating the involvement of nNOS in cytochrome
c release. In addition, increased levels of protein nitration in
the isolated mitochondrial preparation were detected when
mitochondria were subjected to hypoxia reoxygenation (see
Figure 10).
DISCUSSION
The role and mechanisms of NO-induced cell death,
apoptosis, or necrosis has attracted growing interest over
the past few years. It has become clear that NO can either
suppress apoptosis or activate the cell death program,24–26
depending on its concentration, the concomitant presence of
reactive oxygen intermediates (originating in the I/R
process), and the involvement/induction of intracellular
defense mechanisms.
Here, we confirm reports by other authors27,28 that NO
activates apoptosis in the renal I/R model. The fact that NO
inhibition decreases apoptotic parameters (see Figures 3–6)
suggests that it modulates the apoptotic response.
Among the possible mechanisms by which NO induces
apoptosis, direct action on p53 and HIF-1 has been proposed
previously.29 Other studies have attributed its role in
apoptosis to its reaction with superoxide to form peroxy-
nitrite, a strongly cytotoxic molecule that exerts a necrotic or
apoptotic action in many cells.11,30,31 Our results indicate
that peroxynitrite production is involved in apoptosis
generation, as prior administration of a peroxynitrite
scavenger reduced the increase in apoptotic parameters
owing to I/R.
It has been suggested that peroxynitrite enhances C3
activity directly, but exactly how it causes the activation of
the caspase-3 remains to be established.32 Here, we found
that in kidney I/R one of the apoptotic parameters that the
administration of a peroxynitrite scavenger is able to reduce
is cytochrome c release. Cytochrome c release is involved in
the activation of caspase-3.
I/R of organs and cells could induce apoptosis through a
complicated series of changes in mitochondria, such as the
generation of oxygen free radicals, permeability transitions,
calcium translocations, or release of apoptogenic factors such
as cytochrome c and Bcl-2 family members.
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Figure 9 | Representative Western blot for cytochrome c content
in pellet (p; mitochondria) vs supernatant (s; medium) fractions
of isolated mitochondria, experiments (n¼ 3). (a) Control group;
(b) H/R (hypoxia/reoxygenation) group; and (c), H/Rþ L-N-omega-
propyl-L-arginine (L-NPA) (hypoxia/reoxygenationþ nNOS inhibitor
N-omega-propyl-L-arginine). * Po0.05 vs medium.
70 kDa
45 kDa
40 kDa
30 kDa
1        2
DO
 1                                2
70 kDa 658.25 ± 52.8 1325.89 ± 47.6*
45 kDa 921.33 ± 50.0 1423.65 ± 46.3*
40 kDa 764.30 ± 55.5 923.41 ± 39.6*
30 kDa 432.85 ± 56.7 854.26 ± 42.4*
a
b
Figure 10 | (a) Representative Western blot for nitrotyrosine of
isolated mitochondria. 1, Control; 2, I/R (n¼ 3). (b) Densitometric
analysis of nitrotyrosine bands corresponding to 70, 45, 40, and
30 kDa (n¼ 3). 1, Control; and 2, I/R; Data are expressed as mean7s.d.
*Po0.05 vs C.
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We focused on mitochondria in this study owing to the
existence of an mNOS, and the fact that it is the main source
of cytochrome c and one of the main pathways of apoptosis.
Despite the evidence of a mitochondrial location of NOS and
the broadening spectrum of NO actions on mitochondrial
respiration and apoptosis, the basis for interaction between
the enzyme and the organelle remains obscure. Although a
range of mNOSs have been described,22 the most recent
studies evidenced that mNOs is a neuronal constitutive
enzyme.33
In this study, we isolated the mitochondrial and cytosolic
parts of the renal biopsies to differentiate the expression and
the nature of the enzyme by RT-PCR reaction. In accordance
with the recent studies mentioned above, we found an
upregulation of NOS in the mitochondrial fraction of I/R
groups corresponding only to nNOS. No bands were found
in the mitochondrial fraction for iNOS or eNOS in controls
or in I/R groups (data not shown). We also detected increases
in the nitrite production in I/R kidneys. This increase was
reduced when NOS activity was inhibited through L-NAME
and when peroxynitrite was scavenged (Figure 7). Intra-
mitochondrial nitrated protein bands were also increased in
I/R animals, reflecting the activation of the NOS, and
reduced by both L-NAME and FeTMPyP administration
(Figure 1), revealing that NO is able to nitrate protein inside
the mitochondria and also to produce peroxynitrite.
In order to directly assess the mitochondrial nNOS
involvement in cytochrome c release, we performed an
additional experiment in which isolated kidney mitochondria
underwent hypoxia in the presence or absence of an nNOS
inhibitor. Hypoxia/reoxygenation induced a massive release
of mitochondrial cytochrome c into the supernatant and
previous inhibition of nNOS was able to maintain a large
amount of cytochrome c inside the mitochondria, indicating
that nNOS is directly involved in cytochrome c release under
hypoxic or ischemic stimulus.
These results suggest that mitochondrial nNOS upregula-
tion together with the increase in NO production is involved
in the generation of intramitochondrial peroxynitrite, thus
resulting in cytochrome c release and apoptosis induction in
I/R. Obviously, we cannot rule out a direct role of NO in
apoptosis in our model owing to the fact that apoptotic
parameters were reversed when L-NAME was used.
In conclusion, mitochondrial NOS appears to be one of
the most important sources of peroxynitrite generation,
leading to the release of the cytochrome c and apoptosis
promotion in renal I/R.
MATERIALS AND METHODS
Animals and surgical procedures
The study was performed using male Wistar rats (Ifa Credo,
Barcelona, Spain) weighing 250–300 g. The experimental procedures
were conducted under the supervision of our institution’s Research
Commission and followed EU guidelines for handling and care of
laboratory animals. The animals were anesthetized with pentobar-
bitone sodium (50 mg/kg; Euta-Lender, Madrid, Spain) and placed
in a supine position with body temperature maintained at 36–371C.
The abdominal area was covered with saline-soaked gauze at 371C
and a plastic cover to minimize dehydration of exposed tissues.
Renal I/R. After laparotomy and dissection of both renal
pedicles, bilateral ischemia was induced by occluding the renal
pedicles with an atraumatic microvascular clamp for 45 min. The
immediate color change of the kidneys signifying the stoppage of
blood flow indicated successful occlusion. During reperfusion,
clamps were removed and the blood flow to the kidneys was re-
established with visual verification of blood return.
Animal experimental groups. The following experimental
groups (n¼ 6 per group) were studied:
Group 1: Control (C) – Animals with identical maneuvers as the
I/R group, except that the renal pedicles were not clamped.
Group 2: I/R – Animals were subjected to 45 min of bilateral
ischemia and 24 h of reperfusion.
Group 3: I/RþNAME – The animals were subjected to the same
procedure as in group 2 but were also treated with the NOS
inhibitor L-NAME (10 mg/kg, intravenous bolus) administered
5 min before ischemia.34
Group 4: I/Rþ FeTMPyP – As in the previous group, but with the
administration of the peroxynitrite scavenger FeTMPyP (30 mg/kg,
intravenously) dissolved in 300ml of saline, 2 min after the
beginning of reperfusion by direct puncture in the inferior cava.
This dose has been shown to be effective in the rat.35
At the end of the reperfusion period, tissue kidney samples for all
groups were freeze-clamped, removed, and maintained at 801C
until further analysis.
The pharmacological compounds were tested in control groups
to evaluate their possible effects on the different parameters of this
study. The results showed no differences compared with control
animals, and no interaction between drugs and the parameters
measured.
Isolation and mitochondrial experimental procedures
Isolation of renal mitochondria. Mitochondria were extracted
by differential centrifugations following Reinhart et al.36 with some
modifications. Briefly, the tissue were minced and homogenated at
41C in homogenization buffer containing 3 mM Tris-HCl, 220 mM
manitol, 70 mM sucrose, 0.1 mM ethylenediaminetetraacetic acid,
antiprotease cocktail (Sigma-Aldrich chemie, Steinheim, Germany),
and 0.1% bovine serum albumin (pH 7.2). Mitochondria were
separated from the supernatants at 41C without delay using
differential centrifugations to remove cell debris and nuclei. The
resulting mitochondrial pellet was resuspended in a respiratory
buffer containing 5 mM HEPES, 220 mM manitol, 70 mM sucrose,
1 mM KH2PO4, 5 mM succinate, 0.1 mM ethylenediaminetetraacetic
acid, and 0.1% bovine serum albumin (pH 7.2). Protein concentra-
tion of the mitochondrial suspension was determined using a
commercial kit from BioRad (Munich, Germany).
Mitochondrial purity and assessment of contamination by
subcellular organelles were ascertained by the specific activity of
succinic dehydrogenase.37 In order to assess the viability of the
mitochondria, we assayed the oxygen uptake of the suspension
following Simon et al.38 with a Clark-type chamber at 371C. Briefly,
oxygen consumption was checked as follows: 200 mM adenosine
diphosphate was added to 225 ml of mitochondria suspension in
2.5 ml of respiratory buffer to initiate the viability register.
Hypoxia/reoxygenation of mitochondria. After obtaining the
mitochondria and in order to address the involvement of
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mitochondrial nNOS, we performed an additional experiment in
which isolated kidney mitochondria were subjected to hypoxia with
or without the nNOS inhibitor N-omega-propyl-L-arginine. Once
the viability was corroborated, we allowed total oxygen depletion.
Hereafter, we started the hypoxic period by blocking oxygen access
to the sample. In order to mimic the ischemic tissue conditions, we
performed 45 min of hypoxia. The pO2 was measured during the
hypoxic period. The value obtained was around 0–0.2 mm Hg, a
figure that was maintained during the 45 min of hypoxia.
Reperfusion was carried out allowing oxygen return to the
suspension for 2 h. The period of reperfusion was selected based
on the maximum period of mitochondrial viability during
reperfusion.
As pharmacological compounds, we used 50 mM of the selective
nNOS inhibitor N-omega-propyl-L-arginine.39,40
Biochemical analysis
C3 activity. Caspase-3-like activity was determined by measur-
ing proteolytic cleavage of the specific substrate N-acetyl-Asp-Glu-
Val-Asp-7-amino-4-methylcoumarin (Biomol, Plymouth Meeting,
PA, USA). Renal tissue was homogenated and sonicated in assay
buffer (50 mM HEPES, 10% sucrose, 0.1% CHAPS, 5 mM oxidized
glutathione, 5 mM dithiothreitol). We used 25 mg of protein of each
sample and 12 mM N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl-
coumarin to perform the assay. The amino-4-methylcoumarin
released was quantified for 1 h at 371C by fluorospectrophotometry
using 380 nm excitation and measurement of 450 nm emission.
Nitrite tissue accumulation
Nitrite tissue accumulation was determined using a modification of
the method used by Donnelly and Barnes.41 Briefly, 200ml of media
or nitrite standard solution was mixed with 100 ml of 2% (wt/vol)
charcoal in 0.2% (wt/vol) dextran. The suspension was centrifuged
at 10 000 g for 10 min, and the cleared supernatant was mixed with
10 ml of 0.05 mg/ml 2,3-diaminonaphthalene in 0.625 M HCl and
incubated in the dark for 10 min. The reaction was stopped
by the addition of 10 ml of 1.4 M NaOH, and fluorescence was
measured with the excitation wavelength set at 360 nm and the
emission wavelength set at 460 nm. The amount of nitrite in the
sample was calculated using a standard curve of known nitrite
concentrations.
Protein concentration. Total protein concentration in homo-
genates was determined using a commercial kit from BioRad
(Munich, Germany).
Western blot analysis
Equal amounts of protein from mitochondrial and cytosolic
fractions, and isolated mitochondria (30 mg nitrotyrosine, 50 mg
cytochrome c) were electrophoresed in 10% for nitrotyrosine and
15% for cytochrome c sodium dodecyl sulfate gel and transferred to
nitrocellulose membranes, which were subsequently blocked with
5% nonfat dry milk in 0.06% Tween-Tris-buffered saline for 1 h. The
membranes were incubated overnight with primary antibody (anti-
nitrotyrosine 1/1000 or anti-cytochrome c 1/1000, respectively) at
41C, washed five times with Tween-Tris-buffered saline, and incu-
bated for 1 h with anti-rabbit immunoglobulin G for nitrotyrosine
(1:2500) or with horseradish peroxidase-conjugated antimouse
immunoglobulin G antibody for cytochrome c (dilution 1:2000)
at room temperature, followed by enhanced chemoluminescence
detection.
TUNEL assay
TUNEL assay was performed to detect apoptosis in situ. Renal tissue
sections were deparaffinized and rehydrated through three changes
between xylene and graded alcohol, later washed in phosphate-
buffered saline for 5 min, and then incubated in 20 mg/ml proteinase
K for 15 min at room temperature. The DNA fragmentation
detection Kit Colorimetric-TdT Enzyme (Oncogene Research
products, Boston, MA, USA) was used according to the manufac-
turer’s instructions. Briefly, endogenous peroxidase activity in the
kidney sections was blocked by incubation for 5 min with 3% H2O2
in phosphate-buffered saline, followed by incubation for 10 s with
equilibration buffer. The sections were then incubated for 60 min at
371C with terminal deoxynucleotidyl transferase enzyme in reaction
buffer. The reaction was finished by incubation with stopping buffer
at room temperature. Sections were then incubated with peroxidase
conjugated anti-digoxigenin antibody for 30 min at room tempera-
ture, and the reaction was developed with diaminobenzidine
substrate for 4 min at room temperature. Sections were counter-
stained with methyl green stain, dehydrated through a graded series
of alcohol, and mounted in Permount for microscopy.
RNA preparation and RT-PCR
Total RNA from mitochondrial fraction of kidney specimens was
prepared with TRIzol Reagent according to the manufacturer’s
instructions (GibcoBRL, Life Technologies, Carlsbad, CA, USA), and
RNA concentrations were calculated from A260 determinations. RNA
integrity and loading amounts were assessed by examining 18S and
28S ribosomal RNA banding of samples electrophoresed in 1%
agarose gel and stained with ethidium bromide. Analysis of NOS
mRNA expression was conducted by a semiquantitative RT-PCR
method. Total RNA (1 mg) was used and the sequences amplified by
the Life Technologies One Step RT-PCR System according to the
manufacturer’s protocol. The forward primer for rat iNOS was
5-CAT-GGT-GAA-CAC-GTT-CTT-GG-3 and the reverse primer
was 5-GTG-GTG-ACA-AGC-ACA-TTT-GG-3; the forward primer
for rat eNOS was 5-ATG-GAT-GAG-CCA-ACT-CAA-GG-3 and the
reverse primer was 5-CTG-TCC-TCA-GGA-GGT-CTT-GC-3; and
the forward primer for rat nNOS was 5-GAC-AAC-GTT-CCT-GTG-
GTC-CT-3 and the reverse primer was 5-TCC-TTG-AGC-TGG-
TAG-GTG-CT-3.
Fragments were amplified by 35 cycles of PCR, each cycle
consisting of 15 s at 941C, 30 s at 551C, and 1 min at 721C. The
resulting RT-PCR products and the DNA markers were subjected to
electrophoresis in 2% agarose gels, stained with ethidium bromide,
and visualized under UV light. b-Actin was used as internal control
for stable expression (housekeeping gene) in all experiments. In this
case, the forward primer was 50-TCATGAAGTGTGACGTTGA
CATCCGT-30 and the reverse primer was 50-CCTAGAAGCATT
TGCGGTGCACGATG-30.
Statistical analysis
The means of different groups were compared using a two-way
analysis of variance. The Student–Newman–Keuls test was performed
in order to evaluate significant differences between groups, which
were assumed to exist when Po0.05.
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